Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Targeted Cell Therapies

2006 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Angel LATEST DEAL TYPE
2 INVESTORS
Description

Provider of a technology platform in oral delivery sector. The company offers delivery technology platform to address needs in the oral delivery of large molecule drugs for a broad range of disease conditions.

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Drug Delivery
Primary Office
  • 60 Prescott Street
  • Worcester, MA 01605
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Targeted Cell Therapies’s full profile, request a free trial.

Targeted Cell Therapies Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Angel (individual) 31-Oct-2013 00000 Completed Startup
1. Seed Round 06-Dec-2007 00000 00000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Targeted Cell Therapies Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Kin-Joe Sham Angel (individual) Minority 000 0000 000000 0
Seth Ginns Angel (individual) Minority 000 0000 000000 0

Targeted Cell Therapies Executive Team (3)

Name Title Board
Seat
Contact
Info
Edward Ginns Ph.D Co-Founder, Interim CEO & President
Siddarth Rathi MD Chief Strategy Officer

1 Former Executive

You’re viewing 2 of 3 executives. Get the full list »